Nabriva Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
(WorldNews Health)

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Gary Sender Chief Financial Officer and Francesco Lavino Chief Commercial Officer, will provide a company overview and business update at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at 4:30 p.m. ET. The conference is being held at the Lotte New York Palace in New York, NY. The presentation will be webcast live and may be accessed by visiting the `Investors` section of the...